Functions of the peroxisome proliferator-activated receptor (PPAR) α and β in skin homeostasis, epithelial repair, and morphogenesis

Journal of Investigative Dermatology Symposium Proceedings

Volumn 11, Issue 1, 2006, Pages 30-35

  Icre, Guillaume ^a   Wahli, Walter ^a   Michalik, Liliane ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; FATTY ACID; FATTY ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

CELL SURVIVAL; CONFERENCE PAPER; EPIDERMIS; GENE EXPRESSION; GENE REPRESSION; HAIR FOLLICLE; HAIR GROWTH; KERATINOCYTE; LIGAND BINDING; MORPHOGENESIS; NONHUMAN; PROMOTER REGION; PROTEIN FAMILY; SENSOR; SIGNAL TRANSDUCTION; SKIN; SKIN EPITHELIUM; SKIN FUNCTION; SKIN INJURY; TISSUE REPAIR;

ANIMALS; CYCLOOXYGENASE 2; EPITHELIAL CELLS; HAIR FOLLICLE; HOMEOSTASIS; HUMANS; KERATINOCYTES; MORPHOGENESIS; PPAR ALPHA; PPAR-BETA; SKIN PHYSIOLOGY; WOUND HEALING;

EID: 33748802515     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/sj.jidsymp.5650007     Document Type: Conference Paper

References (33)

1. Alonso LC, Rosenfield RL (2003) Molecular genetic and endocrine mechanisms of hair growth. Horm Res 60:1-13
2. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE et al. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1:260-6
3. Birch M, Tomlinson A, Ferguson MW (2005) Animal models for adult dermal wound healing. Methods Mol Med 117:223-35
4. Delerive P, Fruchart JC, Staels B (2001) Peroxisome proliferator- activated receptors in inflammation control. J Endocrinol 169:453-9
5. Desmouliere A, Chaponnier C, Gabbiani G (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13:7-12
6. Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-88
7. Di-Poi N, Ng CY, Tan NS, Yang Z, Hemmings BA, Desvergne B et al. (2005) Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development. Mol Cell Biol 25:1696-712
8. Di-Poi N, Tan NS, Michalik L, Wahli W, Desvergne B (2002) Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10:721-33
9. Diradourian C, Girard J, Pegorier JP (2005) Phosphorylation of PPARs: from molecular characterization to physiological relevance. Biochimie 87:33-8
10. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B (2001) Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142:4195-202
11. Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W (2006) From molecular action to physiological outputs: peroxisome proliferator-activated receptors (PPARs) are nuclear receptors at the crossroads of key cellular functions. Prog Lip Res 45:120-59
12. Forman BM, Chen J, Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-7
13. Gelman L, Michalik L, Desvergne B, Wahli W (2005) Kinase signaling cascades that modulate peroxisome proliferator-activated receptors. Curr Opin Cell Biol 17:216-22
14. Genolet R, Wahli W, Michalik L (2004) PPARs as drug targets to modulate inflammatory responses ? Curr Drug Targets Inflamm Allergy 3:361-75
15. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-50
16. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421-4
17. Kersten S, Wahli W (2000) Peroxisome proliferator activated receptor agonists. Exs 89:141-51
18. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-23
19. Kostadinova R, Wahli W, Michalik L (2005) PPARs in disease: control mechanisms of inflammation. Curr Med Chem 12:2413-46
20. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG et al. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11:779-91
21. Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J et al. (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 154:799-814
22. Michalik L, Feige JN, Gelman L, Pedrazzini T, Keller H, Desvergne B et al. (2005) Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing. Mol Endocrinol 19:2335-48
23. Midwood KS, Williams LV, Schwarzbauer JE (2004) Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36:1031-7
24. Millar SE (2002) Molecular mechanisms regulating hair follicle development. J Invest Dermatol 118:216-25
25. Muller-Decker K, Leder C, Neumann M, Neufang G, Bayerl C, Schweizer J et al. (2003) Expression of cyclooxygenase isozymes during morphogenesis and cycling of pelage hair follicles in mouse skin: precocious onset of the first catagen phase and alopecia upon cyclooxygenase-2 overexpression. J Invest Dermatol 121:661-8
26. Paus R, Muller-Rover S, Van Der Veen C, Maurer M, Eichmuller S, Ling G et al. (1999) A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 113:523-32
27. Rosenfield RL, Deplewski D, Greene ME (2000) Peroxisome proliferator-activated receptors and skin development. Horm Res 54:269-74
28. Tan NS, Michalik L, Desvergne B, Wahli W (2005) Genetic- or transforming growth factor-beta 1-induced changes in epidermal peroxisome proliferator-activated receptor beta/delta expression dictate wound repair kinetics. J Biol Chem 280:18163-70
29. Tan NS, Michalik L, Di-Poi N, Ng CY, Mermod N, Roberts AB et al. (2004) Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. EMBO J 23:4211-21
30. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M et al. (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15:3263-77
31. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB et al. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84:5788-92
32. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-70
33. Zeng Q, McCauley LK, Wang CY (2002) Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression. J Biol Chem 277:50137-42